Public Relations


"Starting with our proprietary positioning and messaging methodology – LHS Immersion® – we partner with clients to develop integrated communications’ programs that build influence and awareness and reach the right stakeholders, with the right messages at the right time."

--Sharon Correia

Our Public Relations services help our clients educate target audiences about their unique value proposition through corporate and product story development. We build influence and awareness to position our clients and/or their products as the right choice for critical stakeholders.
We provide:

Douglas Russell

Senior Vice President & General Manager

Phone: 617-374-8800 x108
Email: drussell@lavoiehealthscience.com

Sharon Correia

Senior Vice President, Integrated Communications

Phone: 617-374-8800 x105
Email: scorreia@lavoiehealthscience.com

Bell Ringer Merit Award 2016

PAIN: a conversation with highly-regarded speakers, digital content, advocacy group outreach, and media relations. The event drew a standing-room crowd, including several leaders and advocacy groups, to a premier Boston hotel for a networking reception and panel.

@LaVoieGroup

- 11 hours ago

RT @sxbegle: Will an #Alzheimers tsunami wash over us by 2050? Different interventions at different times (primary prevention, slowing MCI-…
@LaVoieGroup

- 14 hours ago

RT @DDNewsOnline: #Protalix touts 12-mos results of Ph3 #clinicaltrials of pregunigalsidase alfa vs #Fabry disease Patients switching from…
@LaVoieGroup

- 1 day ago

Many women do not receive regular mammogram screenings. Continuing to advance breast cancer screening technology is… https://t.co/xMa7n7eGEJ
@LaVoieGroup

- 1 day ago

5 days until BIO Investor Forum⁠ — A premier opportunity to network with executives and investors in the… https://t.co/53BuGuiNTg

Example of Public Relations: Panel Development

PAIN: a Conversation brought together industry leaders to participate in a discussion about opioid addition and the need for alternatives. This panel discussion drew nearly 100 clinicians, scientists, patient advocates, patients, investors and biotech/pharma industry professionals.